Astra-Oxford Vaccine Prevents Average of 70% of Covid Cases

by 24USATVNov. 23, 2020, 4:50 p.m. 44
-

Nov.23 -- A Covid-19 vaccine developed by the University of Oxford and AstraZeneca Plc prevented a majority of people from getting the disease but fell short of the high bar set by Pfizer Inc. and Moderna Inc., according to initial results of a large trial. The vaccine stopped an average of 70% of participants in a study from falling ill, an early analysis of the data show. Suzi Ring reports on "Bloomberg Markets: European Open."

Tags:
-

Related Articles

NEWS

Bridge tragedy could see record hit for insurers | REUTERS

by 24USATVMarch 28, 2024, 9:50 a.m.2
NEWS

Auto Sector Most Affected by Baltimore Bridge, DHL Says

by 24USATVMarch 28, 2024, 8:50 a.m.2
NEWS

Kathy Griffin touring again after health struggles, controversy

by 24USATVMarch 28, 2024, 7:50 a.m.2